119 related articles for article (PubMed ID: 11518560)
21. Cytofluorimetric analysis of a renal tubular cell line and its resistant counterpart.
Rosati A; Decorti G; Klugmann FB; Candussio L; Granzotto M; Melato M; Giraldi T
Anticancer Res; 2000; 20(5B):3403-10. PubMed ID: 11131640
[TBL] [Abstract][Full Text] [Related]
22. Reduced drug accumulation and multidrug resistance in human breast cancer cells without associated P-glycoprotein or MRP overexpression.
Lee JS; Scala S; Matsumoto Y; Dickstein B; Robey R; Zhan Z; Altenberg G; Bates SE
J Cell Biochem; 1997 Jun; 65(4):513-26. PubMed ID: 9178101
[TBL] [Abstract][Full Text] [Related]
23. Inhibition of P-glycoprotein-mediated paclitaxel resistance by reversibly linked quinine homodimers.
Pires MM; Emmert D; Hrycyna CA; Chmielewski J
Mol Pharmacol; 2009 Jan; 75(1):92-100. PubMed ID: 18945821
[TBL] [Abstract][Full Text] [Related]
24. Transport of new non-cross-resistant antitumor compounds of the benzoperimidine family in multidrug resistant cells.
Tkaczyk-Gobis K; Tarasiuk J; Seksek O; Stefanska B; Borowski E; Garnier-Suillerot A
Eur J Pharmacol; 2001 Feb; 413(2-3):131-41. PubMed ID: 11226386
[TBL] [Abstract][Full Text] [Related]
25. The effect of fatty acids and analogues upon intracellular levels of doxorubicin in cells displaying P-glycoprotein mediated multidrug resistance.
Abulrob AN; Mason M; Bryce R; Gumbleton M
J Drug Target; 2000; 8(4):247-56. PubMed ID: 11144235
[TBL] [Abstract][Full Text] [Related]
26. Nuclear immunolocalization of P-glycoprotein in multidrug-resistant cell lines showing similar mechanisms of doxorubicin distribution.
Baldini N; Scotlandi K; Serra M; Shikita T; Zini N; Ognibene A; Santi S; Ferracini R; Maraldi NM
Eur J Cell Biol; 1995 Nov; 68(3):226-39. PubMed ID: 8603675
[TBL] [Abstract][Full Text] [Related]
27. Reversal mechanism of multidrug resistance by verapamil: direct binding of verapamil to P-glycoprotein on specific sites and transport of verapamil outward across the plasma membrane of K562/ADM cells.
Yusa K; Tsuruo T
Cancer Res; 1989 Sep; 49(18):5002-6. PubMed ID: 2569930
[TBL] [Abstract][Full Text] [Related]
28. [Subcellular distribution of daunorubicin in the P-glycoprotein-mediated multidrug-resistant cell line K562/ADR].
Gong Y; Wang Y; Chen F
Zhonghua Zhong Liu Za Zhi; 2001 May; 23(3):184-6. PubMed ID: 11783080
[TBL] [Abstract][Full Text] [Related]
29. Zosuquidar and an albumin-binding prodrug of zosuquidar reverse multidrug resistance in breast cancer cells of doxorubicin and an albumin-binding prodrug of doxorubicin.
Abu Ajaj K; Graeser R; Kratz F
Breast Cancer Res Treat; 2012 Jul; 134(1):117-29. PubMed ID: 22228402
[TBL] [Abstract][Full Text] [Related]
30. Reversal of P-glycoprotein-mediated multidrug resistance is induced by saikosaponin D in breast cancer MCF-7/adriamycin cells.
Li C; Guan X; Xue H; Wang P; Wang M; Gai X
Pathol Res Pract; 2017 Jul; 213(7):848-853. PubMed ID: 28554760
[TBL] [Abstract][Full Text] [Related]
31. Reversal of multidrug resistance by verapamil analogues.
Pereira E; Teodori E; Dei S; Gualtieri F; Garnier-Suillerot A
Biochem Pharmacol; 1995 Aug; 50(4):451-7. PubMed ID: 7646549
[TBL] [Abstract][Full Text] [Related]
32. Enhancement of cellular accumulation of cyclosporine by anti-P-glycoprotein monoclonal antibody MRK-16 and synergistic modulation of multidrug resistance.
Naito M; Tsuge H; Kuroko C; Koyama T; Tomida A; Tatsuta T; Heike Y; Tsuruo T
J Natl Cancer Inst; 1993 Feb; 85(4):311-6. PubMed ID: 7678867
[TBL] [Abstract][Full Text] [Related]
33. L1210 cells cultivated under the selection pressure of doxorubicin or vincristine express common mechanisms of multidrug resistance based on the overexpression of P-glycoprotein.
Bohácová V; Sulová Z; Dovinová I; Poláková E; Barancík M; Uhrík B; Orlický J; Breier A
Toxicol In Vitro; 2006 Dec; 20(8):1560-8. PubMed ID: 16962737
[TBL] [Abstract][Full Text] [Related]
34. Pyronaridine, a novel modulator of P-glycoprotein-mediated multidrug resistance in tumor cells in vitro and in vivo.
Qi J; Wang S; Liu G; Peng H; Wang J; Zhu Z; Yang C
Biochem Biophys Res Commun; 2004 Jul; 319(4):1124-31. PubMed ID: 15194484
[TBL] [Abstract][Full Text] [Related]
35. The fluorescent probe Bodipy-FL-verapamil is a substrate for both P-glycoprotein and multidrug resistance-related protein (MRP)-1.
Crivellato E; Candussio L; Rosati AM; Bartoli-Klugmann F; Mallardi F; Decorti G
J Histochem Cytochem; 2002 May; 50(5):731-4. PubMed ID: 11967284
[TBL] [Abstract][Full Text] [Related]
36. Doxorubicin-resistant variants of human prostate cancer cell lines DU 145, PC-3, PPC-1, and TSU-PR1: characterization of biochemical determinants of antineoplastic drug sensitivity.
David-Beabes GL; Overman MJ; Petrofski JA; Campbell PA; de Marzo AM; Nelson WG
Int J Oncol; 2000 Dec; 17(6):1077-86. PubMed ID: 11078791
[TBL] [Abstract][Full Text] [Related]
37. Modulation of P-glycoprotein-mediated multidrug resistance by acceleration of passive drug permeation across the plasma membrane.
Regev R; Katzir H; Yeheskely-Hayon D; Eytan GD
FEBS J; 2007 Dec; 274(23):6204-14. PubMed ID: 17986257
[TBL] [Abstract][Full Text] [Related]
38. Kinetic analysis in living cells of the inhibition of the P-glycoprotein-mediated efflux of anthracyclines by vinca alkaloids.
Pereira E; Tarasiuk J; Garnier-Suillerot A
Chem Biol Interact; 1998 Jul; 114(1-2):61-76. PubMed ID: 9744556
[TBL] [Abstract][Full Text] [Related]
39. Quantitation of doxorubicin uptake, efflux, and modulation of multidrug resistance (MDR) in MDR human cancer cells.
Shen F; Chu S; Bence AK; Bailey B; Xue X; Erickson PA; Montrose MH; Beck WT; Erickson LC
J Pharmacol Exp Ther; 2008 Jan; 324(1):95-102. PubMed ID: 17947497
[TBL] [Abstract][Full Text] [Related]
40. Comparative evaluation of the intracellular accumulation and DNA binding of idarubicin and daunorubicin in sensitive and multidrug-resistant human leukaemia K562 cells.
Bogush T; Robert J
Anticancer Res; 1996; 16(1):365-8. PubMed ID: 8615637
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
